NovaScan developed a novel, patented technology platform that detects, locates, and stratifies cancer in vivo or ex vivo, in seconds without capital equipment.
NovaScan has developed a patented technology platform and products that detect many types of cancers. NovaScan products had 98+% sensitivity and specificity in more than 400 patients in breast and skin cancer detection. NovaScan also informs on cancer aggresiveness. The company's low cost products are small, simple to use, and provide real time response. First target is surgery for skin cancer; two JVs are signed for other types of cancer.